In a mouse model of azoxymethane/DSS-induced colitis-associated cancer, administration of a MyD88 inhibitor significantly alleviated azoxymethane/DSS-inaduced colitis, resulting in reduced body weight loss and lower mortality rates [24]. The gene discussed is MYD88; the disease is colitis.